Neurodegenerative Diseases: current treatment algorithm and potential investment opportunities covered in a lates research report

This report examines the entire neurodegenerative disease therapy area, with a particular focus on the three most prevalent neurodegenerative disorders: Alzheimer’s disease (AD), Parkinson’s disease (PD) and multiple sclerosis (MS).

Pune, India - March 14, 2018 /MarketersMedia/ —

AD and PD represent the most pressing challenges within the disease cluster, due to rapidly increasing prevalence driven by aging populations. Both AD and PD remain ineffectively treated despite substantial investment into R&D by pharmaceutical companies, due to high clinical trial failure rates. As a result there are no disease-modifying therapies for these two indications, with available treatments able to provide only marginal symptomatic relief. MS, the autoimmune disease of the CNS, contrasts with the rest of this cluster, as it affects a different population demographic, and has a lucrative pharmacological market following breakthrough success in the past decade.
Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-neurodegenerative-diseases-protein-misfolding-targets-and-neuromodulators-dominate-the-first-in-class-pipeline-and-lead-the-way-as-potential-disease-modifying-therapies-in-ad-and-pd
Reasons To Buy
• Appreciate the current clinical and commercial landscapes by considering disease symptoms, pathogenesis, etiology, co-morbidities and complications, epidemiology, diagnosis, prognosis and treatment options.
• Identify leading products and key unmet needs within the market.
• Recognize innovative pipeline trends by analyzing therapies by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using proprietary matrix assessments, first-in-class targets in the pipeline have been assessed and ranked according to clinical potential. Individual matrix assessments are provided for targets categorized into four major classes: protein misfolding, neuromodulators, immunomodulators and neuroprotectants. The most promising first-in-class targets are reviewed in greater detail.
• Consider first-in-class pipeline products with no prior involvement in licensing and co-development deals, which may represent potential investment opportunities.
Get this report at: https://www.themarketreports.com/report/buy-now/935553
Scope
• Unmet need is extremely high in AD and PD, with MS showing continued promise in the development of effective therapies
• What are the most important etiological risk factors and pathophysiological processes implicated in AD, PD and MS?
• What is the current treatment algorithm?
• How effective are current therapies for these indications, and how does this impact prognosis?
• The AD pipeline is large and contains a very high proportion of first-in-class product innovation.
• Which molecule types and molecular targets are most prominent across AD, PD and MS?
• What are the connections, in terms of first-in-class innovation, between AD, PD and MS?
• Which first-in-class targets are most promising?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935553

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/neurodegenerative-diseases-current-treatment-algorithm-and-potential-investment-opportunities-covered-in-a-lates-research-report/314330

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-neurodegenerative-diseases-protein-misfolding-targets-and-neuromodulators-dominate-the-first-in-class-pipeline-and-lead-the-way-as-potential-disease-modifying-therapies-in-ad-and-pd%20

Source: MarketersMedia

Release ID: 314330

Latest News

Asian shares slip on trade worries, oil gives up some gains

Jun 25, 2018

By Hideyuki SanoTOKYO (Reuters) - Asian shares fell on Monday on escalating trade tensions between the United States and major economies while oil prices gave up some of their hefty gains made after major oil producers agreed to a modest increase in production.S&P500 mini futures eased as much as 0.6 percent in early trade while MSCI's broadest index of Asia-Pacific shares outside Japan fell 0.25 percent. Japan's Nikkei lost 0.4 percent.The falls were triggered by a report from the Wall Street Journal that U.S. President Donald Trump plans to bar many Chinese companies from investing in U.S. technology firms and...

NZ central bank set to keep low rates as growth slows, trade woes cloud outlook

Jun 25, 2018

By Leika KiharaWELLINGTON (Reuters) - New Zealand's central bank is set to keep interest rates on hold this week and signal that no monetary tightening is on the cards in the near-term, with inflation subdued and escalating global trade friction clouding the outlook for an already slowing economy.All 16 economists polled by Reuters expect the Reserve Bank of New Zealand (RBNZ) to hold rates at 1.75 percent at its rate review on Thursday.Markets are on the lookout for any tweak governor Adrian Orr - who took on the job in March with a pledge to simplify the RBNZ's communication -...

Buoyant euro keeps dollar off 11-month highs, trade issues in focus

Jun 25, 2018

By Shinichi SaoshiroTOKYO (Reuters) - The buoyant euro kept the dollar from hitting an 11-month high on Monday, with trade issues between the United States and the European Union seen deciding the near-term direction for the currencies.The euro was 0.05 percent higher at $1.1662 after gaining about 0.5 percent on Friday. The single currency was lifted after Friday's upbeat German and French business activity data and fresh assurances by Italian politicians that their nation would not leave the single currency.The dollar index against a basket of six major currencies stood at 94.515 having retreated from 95.529, its highest level since...

New Zealand leader leaves hospital 3 days after giving birth

Jun 25, 2018

WELLINGTON, New Zealand — New Zealand Prime Minister Jacinda Ardern and her partner have named their baby daughter Neve and say they want her to grow up in a world in which she can make choices about her family and career based on what she wants. Ardern made her first public appearance on Sunday since giving birth to her daughter on Thursday. She answered a few questions from reporters while holding her baby at Auckland City Hospital before she planned on returning home. She will take six weeks of leave before returning to work. Ardern is just the second elected...

Against the grain: Australian banks face rural lending reckoning

Jun 25, 2018

By Byron KayeSYDNEY (Reuters) - Australian potato farmer Tom Fox says he had never missed a bank payment in two decades before a delay sending a shipment to Indonesia during a trade dispute between the countries prompted his lender to force him into receivership in 2013."I got a letter from the bank lawyers saying I had 12 hours to come up with A$2.4 million ($1.8 million), and that was an impossibility to do on that notice," Fox told Reuters.A third-generation farmer who built up the country's biggest seed potato producer, Fox said his farm and equipment were sold below value...

Stock Markets

About Us

The Morning Herald is a fast news provider in the United States since 2005. Fiercely independent and armed with irreverent intelligence, there’s no other place to get your news other than The Morning Herald.

Contact us: sales[at]themorningherald.com

Subscribe Now!